| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mannose-Binding Lectin | 46 | 2016 | 145 | 5.800 |
Why?
|
| Complement Activation | 18 | 2016 | 445 | 1.660 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 9 | 2012 | 20 | 1.240 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2014 | 187 | 1.140 |
Why?
|
| Lectins | 7 | 2016 | 489 | 1.090 |
Why?
|
| Mannose-Binding Lectins | 6 | 2013 | 96 | 1.020 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 14 | 2014 | 28 | 1.010 |
Why?
|
| Complement Pathway, Alternative | 12 | 2014 | 113 | 1.000 |
Why?
|
| Teichoic Acids | 6 | 2016 | 69 | 0.870 |
Why?
|
| Thrombin | 5 | 2021 | 593 | 0.860 |
Why?
|
| Staphylococcal Infections | 9 | 2016 | 1401 | 0.830 |
Why?
|
| Complement C3 | 9 | 2012 | 434 | 0.790 |
Why?
|
| Complement Factor B | 3 | 2021 | 57 | 0.790 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2013 | 254 | 0.770 |
Why?
|
| Complement System Proteins | 9 | 2016 | 737 | 0.740 |
Why?
|
| Influenza A virus | 5 | 2014 | 458 | 0.730 |
Why?
|
| Trypsin | 1 | 2021 | 486 | 0.700 |
Why?
|
| Staphylococcus aureus | 12 | 2016 | 1450 | 0.690 |
Why?
|
| Collectins | 4 | 2016 | 18 | 0.660 |
Why?
|
| Cell Wall | 5 | 2016 | 417 | 0.650 |
Why?
|
| Immunity, Innate | 12 | 2016 | 3044 | 0.550 |
Why?
|
| Arthritis, Experimental | 7 | 2013 | 291 | 0.530 |
Why?
|
| Mice, Knockout | 40 | 2021 | 14392 | 0.470 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2013 | 120 | 0.450 |
Why?
|
| Antiviral Agents | 6 | 2013 | 3048 | 0.440 |
Why?
|
| Immunoglobulin G | 10 | 2016 | 4537 | 0.420 |
Why?
|
| Mice | 69 | 2024 | 81326 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 37 | 2024 | 22127 | 0.410 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2013 | 355 | 0.390 |
Why?
|
| Disease Susceptibility | 6 | 2011 | 1791 | 0.370 |
Why?
|
| Blood Coagulation | 3 | 2011 | 1156 | 0.370 |
Why?
|
| Phagocytosis | 9 | 2016 | 1525 | 0.370 |
Why?
|
| Radiopharmaceuticals | 6 | 2024 | 2683 | 0.370 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2012 | 80 | 0.360 |
Why?
|
| Inflammation | 15 | 2014 | 10759 | 0.350 |
Why?
|
| Reperfusion Injury | 8 | 2012 | 1026 | 0.350 |
Why?
|
| Animals | 82 | 2024 | 168079 | 0.340 |
Why?
|
| Positron-Emission Tomography | 8 | 2024 | 6585 | 0.330 |
Why?
|
| Influenza, Human | 4 | 2016 | 1521 | 0.290 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2016 | 447 | 0.280 |
Why?
|
| Immunologic Factors | 2 | 2013 | 1589 | 0.280 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 3726 | 0.280 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 696 | 0.270 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2006 | 66 | 0.270 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2006 | 67 | 0.270 |
Why?
|
| Complement C1q | 8 | 2012 | 93 | 0.260 |
Why?
|
| Complement Pathway, Classical | 6 | 2014 | 91 | 0.260 |
Why?
|
| Horse Diseases | 1 | 2006 | 55 | 0.260 |
Why?
|
| Dermis | 1 | 2007 | 202 | 0.250 |
Why?
|
| Antibody Formation | 2 | 2010 | 1391 | 0.240 |
Why?
|
| Burns | 2 | 2007 | 1875 | 0.240 |
Why?
|
| Fluorine Radioisotopes | 2 | 2024 | 420 | 0.240 |
Why?
|
| Ebolavirus | 3 | 2013 | 247 | 0.240 |
Why?
|
| Opsonin Proteins | 5 | 2016 | 144 | 0.230 |
Why?
|
| Epidermis | 1 | 2007 | 526 | 0.230 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3210 | 0.230 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 295 | 0.230 |
Why?
|
| Mannose | 3 | 2010 | 121 | 0.220 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.210 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 30 | 0.210 |
Why?
|
| Radioactive Tracers | 1 | 2022 | 68 | 0.210 |
Why?
|
| 4-Aminopyridine | 1 | 2022 | 80 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 2 | 2014 | 3840 | 0.200 |
Why?
|
| Thiourea | 1 | 2022 | 68 | 0.200 |
Why?
|
| Disease Models, Animal | 14 | 2018 | 18220 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 621 | 0.190 |
Why?
|
| Immunoglobulin M | 5 | 2010 | 1527 | 0.180 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1130 | 0.180 |
Why?
|
| Isoflurane | 1 | 2024 | 384 | 0.180 |
Why?
|
| Calcium Channels, L-Type | 1 | 2022 | 241 | 0.180 |
Why?
|
| Glycoproteins | 4 | 2016 | 2203 | 0.180 |
Why?
|
| Immunization | 4 | 2016 | 1218 | 0.180 |
Why?
|
| Communicable Diseases | 2 | 2008 | 873 | 0.180 |
Why?
|
| Antibodies, Bacterial | 4 | 2016 | 1464 | 0.180 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 352 | 0.170 |
Why?
|
| Peritonitis | 1 | 2002 | 368 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 753 | 0.170 |
Why?
|
| Complement C4 | 5 | 2012 | 216 | 0.160 |
Why?
|
| Myocardium | 4 | 2012 | 4746 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2008 | 17897 | 0.160 |
Why?
|
| Collagen Type II | 2 | 2009 | 148 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 2024 | 0.150 |
Why?
|
| Phagosomes | 2 | 2010 | 199 | 0.150 |
Why?
|
| Phylogeny | 2 | 2021 | 2809 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2006 | 1301 | 0.140 |
Why?
|
| Molecular Imaging | 2 | 2022 | 818 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 5 | 2012 | 509 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 2 | 2011 | 392 | 0.140 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 575 | 0.140 |
Why?
|
| Ligands | 4 | 2024 | 3264 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 404 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2740 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 204 | 0.130 |
Why?
|
| Macrophages, Alveolar | 2 | 2014 | 410 | 0.130 |
Why?
|
| Neuralgia | 1 | 2022 | 612 | 0.130 |
Why?
|
| Brain | 6 | 2024 | 27092 | 0.130 |
Why?
|
| Complement C6 | 2 | 2012 | 14 | 0.130 |
Why?
|
| Polysaccharides | 3 | 2012 | 1014 | 0.130 |
Why?
|
| Adipocytes | 2 | 2013 | 1190 | 0.120 |
Why?
|
| Models, Biological | 3 | 2012 | 9457 | 0.120 |
Why?
|
| Liver | 3 | 2010 | 7514 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 698 | 0.120 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1751 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13402 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 78 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2016 | 352 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 480 | 0.110 |
Why?
|
| Extracorporeal Circulation | 1 | 2014 | 181 | 0.110 |
Why?
|
| Filoviridae Infections | 1 | 2013 | 6 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 116 | 0.110 |
Why?
|
| Neutrophils | 4 | 2016 | 3763 | 0.110 |
Why?
|
| Binding Sites | 2 | 2021 | 5988 | 0.110 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2011 | 87 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2016 | 577 | 0.110 |
Why?
|
| Receptors, Mitogen | 1 | 2013 | 61 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 436 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3366 | 0.110 |
Why?
|
| Artificial Organs | 1 | 2014 | 149 | 0.110 |
Why?
|
| Receptors, Complement | 2 | 2011 | 254 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3803 | 0.100 |
Why?
|
| Solubility | 3 | 2010 | 1085 | 0.100 |
Why?
|
| Cell Division | 1 | 2020 | 4451 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2012 | 725 | 0.100 |
Why?
|
| Onium Compounds | 1 | 2012 | 27 | 0.100 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 8 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 83 | 0.100 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2011 | 50 | 0.100 |
Why?
|
| Autoradiography | 1 | 2013 | 729 | 0.100 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2020 | 2925 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6504 | 0.100 |
Why?
|
| Cryptococcus | 1 | 2011 | 28 | 0.100 |
Why?
|
| Spleen | 3 | 2014 | 2290 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2013 | 196 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2010 | 238 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.090 |
Why?
|
| Antigens, Fungal | 1 | 2011 | 69 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 350 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 284 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2010 | 12 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2014 | 5103 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 207 | 0.090 |
Why?
|
| Leukocytes | 2 | 2013 | 2025 | 0.090 |
Why?
|
| Epitopes | 2 | 2016 | 2504 | 0.090 |
Why?
|
| Chagas Disease | 1 | 2012 | 167 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2010 | 34 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 229 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1885 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 164 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 206 | 0.090 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 300 | 0.090 |
Why?
|
| Aminopyridines | 2 | 2024 | 573 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1031 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2010 | 195 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 4340 | 0.090 |
Why?
|
| Complement C3a | 2 | 2011 | 66 | 0.090 |
Why?
|
| Viral Load | 4 | 2016 | 3328 | 0.090 |
Why?
|
| Protein Binding | 6 | 2016 | 9297 | 0.090 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2009 | 1 | 0.090 |
Why?
|
| Complement Inactivator Proteins | 1 | 2009 | 74 | 0.080 |
Why?
|
| Phagocytes | 1 | 2011 | 294 | 0.080 |
Why?
|
| Complement Factor D | 4 | 2011 | 67 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 117 | 0.080 |
Why?
|
| Complement Factor H | 1 | 2009 | 110 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2013 | 496 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 10756 | 0.080 |
Why?
|
| Hemangioma | 1 | 1994 | 727 | 0.080 |
Why?
|
| Coxiella burnetii | 1 | 2009 | 37 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 748 | 0.080 |
Why?
|
| Humans | 45 | 2021 | 761208 | 0.080 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 11067 | 0.080 |
Why?
|
| Cytokines | 6 | 2019 | 7386 | 0.080 |
Why?
|
| Hepatitis B Antibodies | 1 | 2009 | 155 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2451 | 0.080 |
Why?
|
| Virus Replication | 2 | 2016 | 2426 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2008 | 344 | 0.080 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Macrophages | 3 | 2012 | 5753 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2631 | 0.070 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 501 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 812 | 0.070 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2007 | 15 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 823 | 0.070 |
Why?
|
| Choroidal Neovascularization | 1 | 2011 | 364 | 0.070 |
Why?
|
| Rats | 5 | 2022 | 23704 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 61 | 0.070 |
Why?
|
| Complement C4b | 1 | 2007 | 125 | 0.070 |
Why?
|
| Pneumonia | 1 | 2019 | 2142 | 0.070 |
Why?
|
| Dimerization | 1 | 2008 | 887 | 0.070 |
Why?
|
| Blister | 1 | 2007 | 86 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6567 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 730 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1597 | 0.070 |
Why?
|
| Sepsis | 2 | 2014 | 2585 | 0.070 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1518 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 515 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 221 | 0.070 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2012 | 659 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 9477 | 0.060 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 583 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 362 | 0.060 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 419 | 0.060 |
Why?
|
| Cell Line | 5 | 2013 | 15545 | 0.060 |
Why?
|
| Brain Injuries | 2 | 2008 | 2054 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2009 | 537 | 0.060 |
Why?
|
| Horses | 1 | 2006 | 296 | 0.060 |
Why?
|
| Models, Animal | 2 | 2008 | 2115 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 1322 | 0.060 |
Why?
|
| Dermatitis | 1 | 2007 | 202 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3620 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 222 | 0.060 |
Why?
|
| Permeability | 2 | 2022 | 721 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10422 | 0.060 |
Why?
|
| Disulfiram | 1 | 2024 | 63 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2013 | 5032 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2007 | 675 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 324 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 191 | 0.050 |
Why?
|
| Male | 23 | 2024 | 360693 | 0.050 |
Why?
|
| Risk Factors | 4 | 2014 | 74239 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2004 | 405 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2013 | 4137 | 0.050 |
Why?
|
| Kinetics | 2 | 2010 | 6312 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2008 | 4111 | 0.050 |
Why?
|
| Bacteremia | 2 | 2005 | 978 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4567 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2024 | 537 | 0.050 |
Why?
|
| Colitis | 1 | 2010 | 1234 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2175 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1768 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9187 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3671 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 619 | 0.050 |
Why?
|
| Calcium | 2 | 2012 | 5719 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 18384 | 0.050 |
Why?
|
| Cells, Cultured | 6 | 2016 | 18926 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2004 | 465 | 0.050 |
Why?
|
| Haplotypes | 1 | 2007 | 2715 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 1963 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2016 | 48 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17598 | 0.050 |
Why?
|
| Pneumocystis | 1 | 2000 | 55 | 0.050 |
Why?
|
| Mycoses | 1 | 2004 | 386 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 794 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2024 | 1875 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 521 | 0.040 |
Why?
|
| Movement | 1 | 2007 | 1476 | 0.040 |
Why?
|
| Kidney | 3 | 2010 | 7033 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3551 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1246 | 0.040 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 724 | 0.040 |
Why?
|
| Retina | 1 | 2011 | 2655 | 0.040 |
Why?
|
| Lung | 5 | 2011 | 9979 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 162 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3313 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3031 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 834 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3032 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2024 | 573 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2006 | 758 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2000 | 242 | 0.040 |
Why?
|
| Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3320 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2002 | 558 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 2193 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 1272 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2726 | 0.040 |
Why?
|
| Female | 15 | 2018 | 392544 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 268 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2007 | 2846 | 0.040 |
Why?
|
| RNA Interference | 1 | 2006 | 2816 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1390 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 585 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9520 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2005 | 1356 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2016 | 80 | 0.030 |
Why?
|
| Choline | 1 | 2018 | 515 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1283 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 1027 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 1448 | 0.030 |
Why?
|
| Complement C2 | 2 | 2005 | 45 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2802 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4744 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 16575 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12404 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 10088 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2658 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 85 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 97 | 0.030 |
Why?
|
| Aged | 6 | 2018 | 169288 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1685 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3073 | 0.030 |
Why?
|
| Collagenases | 1 | 1994 | 222 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2007 | 3258 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 260 | 0.030 |
Why?
|
| Mast Cells | 2 | 2006 | 1392 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 283 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 2244 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11509 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8603 | 0.030 |
Why?
|
| Pinocytosis | 1 | 2013 | 63 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 286 | 0.030 |
Why?
|
| Brain Edema | 2 | 2008 | 604 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2016 | 546 | 0.030 |
Why?
|
| Complement Fixation Tests | 1 | 2012 | 68 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 172 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2012 | 57 | 0.030 |
Why?
|
| Heart | 1 | 2006 | 4431 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 696 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1923 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 105 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 3832 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 3753 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1994 | 748 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6224 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1967 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 166 | 0.030 |
Why?
|
| Pandemics | 1 | 2012 | 8663 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6505 | 0.020 |
Why?
|
| Alanine Transaminase | 2 | 2005 | 602 | 0.020 |
Why?
|
| Vero Cells | 1 | 2013 | 482 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 588 | 0.020 |
Why?
|
| Endotoxins | 1 | 2014 | 520 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1867 | 0.020 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 672 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 41496 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3493 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4947 | 0.020 |
Why?
|
| Flavonoids | 1 | 2014 | 444 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 974 | 0.020 |
Why?
|
| Magnetics | 1 | 2014 | 598 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3417 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 8164 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 193 | 0.020 |
Why?
|
| Lymphokines | 1 | 1994 | 925 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 631 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14675 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1848 | 0.020 |
Why?
|
| Rabbits | 2 | 2007 | 4750 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 428 | 0.020 |
Why?
|
| Middle Aged | 5 | 2014 | 220853 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2014 | 4201 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9721 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2013 | 532 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9566 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1893 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 378 | 0.020 |
Why?
|
| Immune System | 2 | 2008 | 792 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2011 | 393 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 252 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 64681 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 613 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 639 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3517 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 113 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 274 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 368 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6067 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 254 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5871 | 0.020 |
Why?
|
| Chlorides | 1 | 2011 | 657 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3696 | 0.020 |
Why?
|
| Oximetry | 1 | 2012 | 459 | 0.020 |
Why?
|
| Q Fever | 1 | 2009 | 38 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 524 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 812 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1375 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2009 | 294 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 799 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 302 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20119 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5909 | 0.020 |
Why?
|
| Candidiasis | 1 | 2010 | 365 | 0.020 |
Why?
|
| Microscopy | 1 | 2013 | 904 | 0.020 |
Why?
|
| Zymosan | 1 | 2007 | 134 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1379 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 167 | 0.020 |
Why?
|
| Collagen Type VII | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 956 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 372 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2009 | 389 | 0.020 |
Why?
|
| Immune Sera | 1 | 2007 | 605 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4935 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 552 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 390 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 485 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2009 | 617 | 0.020 |
Why?
|
| Adult | 7 | 2013 | 221119 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2006 | 70 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2009 | 23416 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2412 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11476 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 36169 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3510 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1662 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 30002 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3778 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 399 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15920 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 202 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 1358 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 6199 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2012 | 1611 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1721 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2007 | 286 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2477 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 2051 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 623 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 481 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 123 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15637 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 58952 | 0.020 |
Why?
|
| Troponin I | 1 | 2009 | 652 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1045 | 0.020 |
Why?
|
| Asthma | 1 | 2004 | 6230 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 403 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1762 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 16952 | 0.010 |
Why?
|
| Hypothermia | 1 | 2006 | 188 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 238 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 671 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6223 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 874 | 0.010 |
Why?
|
| Encephalitis | 1 | 2008 | 438 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3818 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4243 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12747 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1140 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2013 | 26199 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 342 | 0.010 |
Why?
|
| Herpes Genitalis | 1 | 2004 | 149 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 2048 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2635 | 0.010 |
Why?
|
| Dextrans | 1 | 2005 | 574 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 448 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 773 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2006 | 803 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8003 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 578 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 157 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1676 | 0.010 |
Why?
|
| Autoantigens | 1 | 2006 | 888 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2007 | 719 | 0.010 |
Why?
|
| Germinal Center | 1 | 2005 | 380 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 610 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 1822 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2012 | 4165 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8998 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 965 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1749 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2000 | 85 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1610 | 0.010 |
Why?
|